Pharmaceuticals Removed from Chemicals of Concern List

Pharmaceuticals Removed from Chemicals of Concern List

Pharmaceuticals Removed from Chemicals of Concern List Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed July 2009 50-06-6 Phenobarbital pharm Dec_2011 July 2009 50-28-2 oestradiol pharm Dec_2011 July 2009 50-35-1 Thalidomide pharm Dec_2011 July 2009 50-36-2 Cocaine pharm Dec_2011 July 2009 50-41-9 Clomiphene citrate pharm Dec_2011 July 2009 50-53-3 chlorpromazine pharm Dec_2011 July 2009 50-55-5 Reserpine pharm Dec_2011 July 2009 50-76-0 Actinomycin D pharm Dec_2011 July 2009 50-78-2 Aspirin pharm Dec_2011 July 2009 51-21-8 Fluorouracil pharm Dec_2011 July 2009 51-52-5 Propylthiouracil pharm Dec_2011 July 2009 51-64-9 dextroamphetamine pharm Dec_2011 July 2009 51-75-2 Nitrogen mustard (Mechlorethamine) pharm Dec_2011 July 2009 51-98-9 Norethisterone acetate (Norethindrone acetate) pharm Dec_2011 July 2009 52-01-7 Spironolactone pharm Dec_2011 July 2009 52-24-4 Tris(1-aziridinyl)phosphine sulfide (Thiotepa) pharm Dec_2011 July 2009 52-28-8 Codeine phosphate pharm Dec_2011 July 2009 52-67-5 Penicillamine pharm Dec_2011 July 2009 52-86-8 Haloperidol pharm Dec_2011 July 2009 53-16-7 oestron pharm Dec_2011 July 2009 54-62-6 Aminopterin pharm Dec_2011 July 2009 54-91-1 Pipobroman pharm Dec_2011 July 2009 55-86-7 Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) pharm Dec_2011 July 2009 55-98-1 1,4-Butanediol dimethanesulfonate (Busulfan) pharm Dec_2011 July 2009 56-04-2 Methylthiouracil pharm Dec_2011 July 2009 56-53-1 diethylstilbestrol pharm Dec_2011 July 2009 56-75-7 Chloramphenicol pharm Dec_2011 July 2009 57-33-0 Pentobarbital sodium pharm Dec_2011 July 2009 57-53-4 Meprobamate pharm Dec_2011 July 2009 57-57-8 beta-Propiolactone pharm Dec_2011 July 2009 57-63-6 17-ethynylestradiol pharm Dec_2011 July 2009 57-83-0 Progesterone pharm Dec_2011 July 2009 58-18-4 Methyltestosterone pharm Dec_2011 July 2009 58-20-8 Testosterone cypionate pharm Dec_2011 July 2009 58-22-0 Testosterone and its esters pharm Dec_2011 July 2009 58-25-3 Chlordiazepoxide pharm Dec_2011 July 2009 59-05-2 Methotrexate pharm Dec_2011 July 2009 59-66-5 Acetazolamide pharm Dec_2011 July 2009 59-92-7 Levodopa pharm Dec_2011 July 2009 59-96-1 Phenoxybenzamine pharm Dec_2011 July 2009 60-54-8 Tetracycline (internal use) pharm Dec_2011 July 2009 60-56-0 Methimazole pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed July 2009 61-57-4 Niridazole pharm Dec_2011 July 2009 62-44-2 Phenacetin pharm Dec_2011 July 2009 64-73-3 Demeclocycline hydrochloride (internal use) pharm Dec_2011 July 2009 64-75-5 Tetracycline hydrochloride (internal use) pharm Dec_2011 July 2009 64-86-8 Colchicine pharm Dec_2011 July 2009 66-75-1 Uracil mustard pharm Dec_2011 July 2009 66-76-2 Dicumarol pharm Dec_2011 July 2009 67-20-9 Nitrofurantoin pharm Dec_2011 July 2009 67-45-8 Furazolidone pharm Dec_2011 July 2009 68-22-4 Norethisterone (Norethindrone) pharm Dec_2011 July 2009 68-23-5 Norethynodrel pharm Dec_2011 July 2009 68-90-6 benziodarone pharm Dec_2011 July 2009 72-33-3 mestranol pharm Dec_2011 July 2009 76-43-7 Fluoxymesterone pharm Dec_2011 July 2009 84-17-3 Dienestrol pharm Dec_2011 July 2009 99-66-1 Valproate (Valproic acid) pharm Dec_2011 July 2009 126-85-2 Nitrogen mustard N-oxide pharm Dec_2011 July 2009 127-07-1 Hydroxyurea pharm Dec_2011 July 2009 127-48-0 Trimethadione pharm Dec_2011 July 2009 141-90-2 Thiouracil pharm Dec_2011 July 2009 143-67-9 Vinblastine sulfate pharm Dec_2011 July 2009 143-81-7 Butabarbital sodium pharm Dec_2011 July 2009 147-94-4 Cytarabine pharm Dec_2011 July 2009 148-82-3 Melphalan pharm Dec_2011 July 2009 151-67-7 Halothane pharm Dec_2011 July 2009 154-42-7 Thioguanine pharm Dec_2011 July 2009 154-93-8 Bischloroethyl nitrosourea (BCNU) (Carmustine) pharm Dec_2011 July 2009 298-46-4 Carbamazepine pharm Dec_2011 July 2009 300-62-9 amphetamine pharm Dec_2011 July 2009 302-70-5 Nitrogen mustard N-oxide hydrochloride pharm Dec_2011 July 2009 302-79-4 All-trans retinoic acid pharm Dec_2011 July 2009 305-03-3 Chlorambucil pharm Dec_2011 July 2009 309-43-3 Secobarbital sodium pharm Dec_2011 July 2009 315-37-7 Testosterone enanthate pharm Dec_2011 July 2009 320-67-2 Azacitidine pharm Dec_2011 July 2009 364-98-7 Diazoxide pharm Dec_2011 July 2009 366-70-1 Procarbazine hydrochloride pharm Dec_2011 July 2009 379-79-3 Ergotamine tartrate pharm Dec_2011 July 2009 389-08-2 Nalidixic acid pharm Dec_2011 July 2009 434-07-1 Oxymetholone pharm Dec_2011 July 2009 435-97-2 Phenprocoumon pharm Dec_2011 July 2009 438-41-5 Chlordiazepoxide hydrochloride pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed July 2009 439-14-5 Diazepam pharm Dec_2011 July 2009 446-86-6 Azathioprine pharm Dec_2011 July 2009 474-25-9 Chenodiol pharm Dec_2011 July 2009 484-20-8 5-Methoxypsoralen with ultraviolet A therapy pharm Dec_2011 July 2009 505-60-2 Mustard Gas pharm Dec_2011 July 2009 531-76-0 Merphalan pharm Dec_2011 July 2009 531-86-2 benzidine sulfate pharm Dec_2011 July 2009 536-33-4 Ethionamide pharm Dec_2011 July 2009 537-46-2 methamphetamine pharm Dec_2011 July 2009 564-25-0 Doxycycline (internal use) pharm Dec_2011 July 2009 590-96-5 Methylazoxymethanol pharm Dec_2011 July 2009 595-33-5 Megestrol acetate pharm Dec_2011 July 2009 604-75-1 Oxazepam pharm Dec_2011 July 2009 630-93-3 Diphenylhydantoin (Phenytoin), sodium salt pharm Dec_2011 July 2009 637-07-0 Clofibrate pharm Dec_2011 July 2009 645-05-6 Altretamine pharm Dec_2011 July 2009 665-66-7 Amantadine hydrochloride pharm Dec_2011 July 2009 671-16-9 Procarbazine pharm Dec_2011 July 2009 749-13-3 trifluperidol pharm Dec_2011 July 2009 797-63-7 Levonorgestrel implants pharm Dec_2011 July 2009 846-49-1 Lorazepam pharm Dec_2011 July 2009 846-50-4 Temazepam pharm Dec_2011 July 2009 919-16-4 Lithium citrate pharm Dec_2011 July 2009 1172-18-5 Flurazepam hydrochloride pharm Dec_2011 July 2009 1405-10-3 Neomycin sulfate (internal use) pharm Dec_2011 July 2009 1620-21-9 Chlorcyclizine hydrochloride pharm Dec_2011 July 2009 2062-78-4 pimozide pharm Dec_2011 July 2009 2068-78-2 Vincristine sulfate pharm Dec_2011 July 2009 3546-10-9 Phenesterin pharm Dec_2011 July 2009 3771-19-5 Nafenopin pharm Dec_2011 July 2009 3963-95-9 Methacycline hydrochloride pharm Dec_2011 July 2009 4291-63-8 Cladribine pharm Dec_2011 July 2009 4342-03-4 Dacarbazine pharm Dec_2011 July 2009 4394-00-7 niflumic acid pharm Dec_2011 July 2009 4759-48-2 Isotretinoin pharm Dec_2011 July 2009 5104-49-4 Flurbiprofen pharm Dec_2011 July 2009 5534-09-8 Beclomethasone dipropionate pharm Dec_2011 July 2009 6055-19-2 Cyclophosphamide (hydrated) pharm Dec_2011 July 2009 6112-76-1 Mercaptopurine pharm Dec_2011 July 2009 6190-39-2 Dihydroergotamine mesylate pharm Dec_2011 July 2009 6533-00-2 Norgestrel pharm Dec_2011 July 2009 7632-10-2 methamphetamine pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed July 2009 9002-68-0 Menotropins pharm Dec_2011 July 2009 10043-66-0 Iodine-131 pharm Dec_2011 July 2009 10418-03-8 Stanozolol pharm Dec_2011 July 2009 10540-29-1 Tamoxifen and its salts pharm Dec_2011 July 2009 13292-46-1 Rifampin pharm Dec_2011 July 2009 13311-84-7 Flutamide pharm Dec_2011 July 2009 13614-98-7 Minocycline hydrochloride (internal use) pharm Dec_2011 July 2009 13647-35-3 Trilostane pharm Dec_2011 July 2009 14028-44-5 Amoxapine pharm Dec_2011 July 2009 15475-56-6 Methotrexate sodium pharm Dec_2011 July 2009 15663-27-1 Cisplatin pharm Dec_2011 July 2009 17086-28-1 Doxycycline monohydrate (internal use) pharm Dec_2011 July 2009 17230-88-5 Danazol pharm Dec_2011 July 2009 18378-89-7 Plicamycin pharm Dec_2011 July 2009 21739-91-3 Cytembena pharm Dec_2011 July 2009 21829-25-4 Nifedipine pharm Dec_2011 July 2009 22494-42-4 Diflunisal pharm Dec_2011 July 2009 23092-17-3 Halazepam pharm Dec_2011 July 2009 23214-92-8 Adriamycin pharm Dec_2011 July 2009 23593-75-1 clotrimazole pharm Dec_2011 July 2009 24390-14-5 Doxycycline hyclate (internal use) pharm Dec_2011 July 2009 25122-46-7 Clobetasol propionate pharm Dec_2011 July 2009 25316-40-9 Doxorubicin hydrochloride (Adriamycin) pharm Dec_2011 July 2009 25812-30-0 Gemfibrozil pharm Dec_2011 July 2009 29122-68-7 Atenolol pharm Dec_2011 July 2009 29767-20-2 Teniposide pharm Dec_2011 July 2009 31431-39-7 Mebendazole pharm Dec_2011 July 2009 33069-62-4 Paclitaxel pharm Dec_2011 July 2009 33286-22-5 Diltiazem hydrochloride pharm Dec_2011 July 2009 33419-42-0 Etoposide pharm Dec_2011 July 2009 34031-32-8 Auranofin pharm Dec_2011 July 2009 36735-22-5 Quazepam pharm Dec_2011 July 2009 36791-04-5 Ribavirin pharm Dec_2011 July 2009 38194-50-2 Sulindac pharm Dec_2011 July 2009 38260-01-4 Trientine hydrochloride pharm Dec_2011 July 2009 39831-55-5 Amikacin sulfate pharm Dec_2011 July 2009 41340-25-4 Etodolac pharm Dec_2011 July 2009 41575-94-4 Carboplatin pharm Dec_2011 July 2009 49842-07-1 Tobramycin sulfate pharm Dec_2011 July 2009 52468-60-7 sibelium pharm Dec_2011 July 2009 53910-25-1 Pentostatin pharm Dec_2011 July 2009 54350-48-0 Etretinate pharm Dec_2011 Pharmaceuticals Removed from Chemicals of Concern List Published by Maine DEP December 30, 2011 Source list last Date CAS Chemical Name Pharmaceutical reviewed Listed July 2009 54749-90-5 Chlorozotocin pharm Dec_2011 July 2009

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us